Georges Gilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Georges Gilson has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
R L Humbel
4 shared publications- Hanen Samouda
Precision Health Department, Luxembourg Institute of Health, Strassen, Luxembourg
3 shared publications - Patrick Schmit
Laboratoire de Biochimie et d’Immunopathologie, Centre Hospitalier de Luxembourg, rue Barblé 4, 1210 Luxembourg, Luxembourg
3 shared publications - Carine de Beaufort
OBEDIA‐Kids Centre Hospitalier de Luxembourg Luxembourg Luxembourg
2 shared publications - Michel Vaillant
Competence Centre for Methodology and Statistics, Department of Medical Informatics, Luxembourg Institute of Health, Luxembourg
2 shared publications S Lamy
2 shared publications
Latest Publications
- 16 May 2020
- Published by Wiley in Pediatric Diabetes
- Vol. 21 (5) , 758-765
Relationship of oxidative stress to visceral adiposity in youth and role played by vitamin D
Background Visceral adipose tissue (VAT) accumulation is a major cardiometabolic risk factor, associated with increased inflammation. Oxidative stress (OS) is also associated with inflammation and cardiometabolic issues, yet mainly through general obesity. Both OS and obesity were linked to vitamin D deficiency. Objectives To investigate whether OS increase is associated with VAT accumulation in youth, and whether in the presence of VAT accumulation, a higher vitamin D status is associated with lower OS. Methods 158 youth with overweight/obesity, 7‐17 years old, were recruited (Paediatric Clinic, Luxembourg). We assessed visceral and subcutaneous abdominal adipose tissues by magnetic resonance imaging, OS by DNA/RNA oxidative damage with ELISA and vitamin D by high‐performance liquid chromatography. Results VAT was the body fat compartment the most strongly associated with OS (RPearson: 0.298; P‐4). The general linear (GLM) models assessing the relationship between OS, VAT and vitamin D concentrations showed that “Log10 OS = (0.003×VAT) + 3.911 (R2adjusted: 0.083; p‐value < 10‐4)”; “Log10 OS = (0.003×VAT) – (0.156× log10 vitamin D) + 4.110 (R2adjusted: 0.101; p‐value < 10‐4)”. After back‐transformation of the log‐values into normal values, the GLM showed that, for a person with an average value of VAT (40.7 cm2), a 10 cm2 increase in VAT would increase OS by approx. 771.833 pg/mL, after age, gender, Tanner stage and physical activity adjustment. An approximate increase of 9 ng/mL of vitamin D would counterbalance this negative effect of increased VAT. Conclusion Dietary strategies improving vitamin D status should be investigated to tackle VAT and OS increase.
- 16 May 2020
- Published by Wiley in Pediatric Diabetes
- Vol. 21 (5) , 758-765
Relationship of oxidative stress to visceral adiposity in youth and role played by vitamin D
Background Visceral adipose tissue (VAT) accumulation is a major cardiometabolic risk factor, associated with increased inflammation. Oxidative stress (OS) is also associated with inflammation and cardiometabolic issues, yet mainly through general obesity. Both OS and obesity were linked to vitamin D deficiency. Objectives To investigate whether OS increase is associated with VAT accumulation in youth, and whether in the presence of VAT accumulation, a higher vitamin D status is associated with lower OS. Methods 158 youth with overweight/obesity, 7‐17 years old, were recruited (Paediatric Clinic, Luxembourg). We assessed visceral and subcutaneous abdominal adipose tissues by magnetic resonance imaging, OS by DNA/RNA oxidative damage with ELISA and vitamin D by high‐performance liquid chromatography. Results VAT was the body fat compartment the most strongly associated with OS (RPearson: 0.298; P‐4). The general linear (GLM) models assessing the relationship between OS, VAT and vitamin D concentrations showed that “Log10 OS = (0.003×VAT) + 3.911 (R2adjusted: 0.083; p‐value < 10‐4)”; “Log10 OS = (0.003×VAT) – (0.156× log10 vitamin D) + 4.110 (R2adjusted: 0.101; p‐value < 10‐4)”. After back‐transformation of the log‐values into normal values, the GLM showed that, for a person with an average value of VAT (40.7 cm2), a 10 cm2 increase in VAT would increase OS by approx. 771.833 pg/mL, after age, gender, Tanner stage and physical activity adjustment. An approximate increase of 9 ng/mL of vitamin D would counterbalance this negative effect of increased VAT. Conclusion Dietary strategies improving vitamin D status should be investigated to tackle VAT and OS increase.
- Open Access
- 24 October 2015
- Published by Springer Nature in BMC Pediatrics
- Vol. 15 (1) , 168
Adding anthropometric measures of regional adiposity to BMI improves prediction of cardiometabolic, inflammatory and adipokines profiles in youths: a cross-sectional study
Paediatric research analysing the relationship between the easy-to-use anthropometric measures for adiposity and cardiometabolic risk factors remains highly controversial in youth. Several studies suggest that only body mass index (BMI), a measure of relative weight, constitutes an accurate predictor, whereas others highlight the potential role of waist-to-hip ratio (WHR), waist circumference (Waist C), and waist-to-height ratio (WHtR). In this study, we examined the effectiveness of adding anthropometric measures of body fat distribution (Waist C Z Score, WHR Z Score and/or WHtR) to BMI Z Score to predict cardiometabolic risk factors in overweight and obese youth. We also examined the consistency of these associations with the “total fat mass + trunk/legs fat mass” and/or the “total fat mass + trunk fat mass” combinations, as assessed by dual energy X-ray absorptiometry (DXA), the gold standard measurement of body composition. Anthropometric and DXA measurements of total and regional adiposity, as well as a comprehensive assessment of cardiometabolic, inflammatory and adipokines profiles were performed in 203 overweight and obese 7–17 year-old youths from the Paediatrics Clinic, Centre Hospitalier de Luxembourg. Adding only one anthropometric surrogate of regional fat to BMI Z Score improved the prediction of insulin resistance (WHR Z Score, R2: 45.9 %. Waist C Z Score, R2: 45.5 %), HDL-cholesterol (WHR Z Score, R2: 9.6 %. Waist C Z Score, R2: 10.8 %. WHtR, R2: 6.5 %), triglycerides (WHR Z Score, R2: 11.7 %. Waist C Z Score, R2: 12.2 %), adiponectin (WHR Z Score, R2: 14.3 %. Waist C Z Score, R2: 17.7 %), CRP (WHR Z Score, R2: 18.2 %. WHtR, R2: 23.3 %), systolic (WHtR, R2: 22.4 %), diastolic blood pressure (WHtR, R2: 20 %) and fibrinogen (WHtR, R2: 21.8 %). Moreover, WHR Z Score, Waist C Z Score and/or WHtR showed an independent significant contribution according to these models. These results were in line with the DXA findings. Adding anthropometric measures of regional adiposity to BMI Z Score improves the prediction of cardiometabolic, inflammatory and adipokines profiles in youth.
- 24 October 2015
- Published by Springer Nature in BMC Pediatrics
- Vol. 15 (1) , 168
Open AccessAdding anthropometric measures of regional adiposity to BMI improves prediction of cardiometabolic, inflammatory and adipokines profiles in youths: a cross-sectional study
Paediatric research analysing the relationship between the easy-to-use anthropometric measures for adiposity and cardiometabolic risk factors remains highly controversial in youth. Several studies suggest that only body mass index (BMI), a measure of relative weight, constitutes an accurate predictor, whereas others highlight the potential role of waist-to-hip ratio (WHR), waist circumference (Waist C), and waist-to-height ratio (WHtR). In this study, we examined the effectiveness of adding anthropometric measures of body fat distribution (Waist C Z Score, WHR Z Score and/or WHtR) to BMI Z Score to predict cardiometabolic risk factors in overweight and obese youth. We also examined the consistency of these associations with the “total fat mass + trunk/legs fat mass” and/or the “total fat mass + trunk fat mass” combinations, as assessed by dual energy X-ray absorptiometry (DXA), the gold standard measurement of body composition. Anthropometric and DXA measurements of total and regional adiposity, as well as a comprehensive assessment of cardiometabolic, inflammatory and adipokines profiles were performed in 203 overweight and obese 7–17 year-old youths from the Paediatrics Clinic, Centre Hospitalier de Luxembourg. Adding only one anthropometric surrogate of regional fat to BMI Z Score improved the prediction of insulin resistance (WHR Z Score, R2: 45.9 %. Waist C Z Score, R2: 45.5 %), HDL-cholesterol (WHR Z Score, R2: 9.6 %. Waist C Z Score, R2: 10.8 %. WHtR, R2: 6.5 %), triglycerides (WHR Z Score, R2: 11.7 %. Waist C Z Score, R2: 12.2 %), adiponectin (WHR Z Score, R2: 14.3 %. Waist C Z Score, R2: 17.7 %), CRP (WHR Z Score, R2: 18.2 %. WHtR, R2: 23.3 %), systolic (WHtR, R2: 22.4 %), diastolic blood pressure (WHtR, R2: 20 %) and fibrinogen (WHtR, R2: 21.8 %). Moreover, WHR Z Score, Waist C Z Score and/or WHtR showed an independent significant contribution according to these models. These results were in line with the DXA findings. Adding anthropometric measures of regional adiposity to BMI Z Score improves the prediction of cardiometabolic, inflammatory and adipokines profiles in youth.
- Open Access
Prevalence and Correlates of Vitamin D Deficiency and Insufficiency in Luxembourg Adults: Evidence from the Observation of Cardiovascular Risk Factors (ORISCAV-LUX) Study
Evidence on vitamin D status and related risk factors in Luxembourg adults is lacking. This study aimed to determine the prevalence of vitamin D deficiency and insufficiency and related risk factors among healthy adults in Luxembourg. Based on clinicians’ observations, it was hypothesized that vitamin D deficiency and insufficiency might be common in our population, constituting a significant public health concern. A nationally representative random sample of 1432 adults was enrolled in the ORISCAV-LUX study, 2007–2008. The participants were divided into four categories according to their serum concentrations of 25-hydroxyvitamin D [25(OH)D]. Descriptive, univariate and multivariate statistical analyses used weighted methods to account for the stratified sampling scheme. Only 17.1% of the population had a “desirable” serum 25(OH)D level ≥75 nmol/L, whereas 27.1% had “inadequate” [serum 25(OH)D level 50–74 nmol/L], 40.4% had “insufficient” [serum 25(OH)D level 25–49 nmol/L], and 15.5% had “deficient” [serum 25(OH)D level <25 nmol/L)]. The prevalence of vitamin D deficiency was greater among current smokers, obese subjects, those having reduced HDL-cholesterol level and fair/poor self-perception of health, compared to their counterparts. The prevalence of vitamin D insufficiency was additionally higher among nondrinkers of alcohol, Portuguese and subjects from non-European countries. The final multivariate logistic regression analyses revealed that smoking status and obesity were independent correlates of vitamin D deficiency and insufficiency, respectively. Inadequate vitamin D status is highly prevalent among adults in Luxembourg and is associated with specific lifestyle factors. Along with the effect of vitamin D deficiency and insufficiency on the risk of several diseases, cancer and mortality, our findings have practical implications for public health dietary recommendations, and of particular importance for healthcare practitioners and policy makers.
Open AccessPrevalence and Correlates of Vitamin D Deficiency and Insufficiency in Luxembourg Adults: Evidence from the Observation of Cardiovascular Risk Factors (ORISCAV-LUX) Study
Evidence on vitamin D status and related risk factors in Luxembourg adults is lacking. This study aimed to determine the prevalence of vitamin D deficiency and insufficiency and related risk factors among healthy adults in Luxembourg. Based on clinicians’ observations, it was hypothesized that vitamin D deficiency and insufficiency might be common in our population, constituting a significant public health concern. A nationally representative random sample of 1432 adults was enrolled in the ORISCAV-LUX study, 2007–2008. The participants were divided into four categories according to their serum concentrations of 25-hydroxyvitamin D [25(OH)D]. Descriptive, univariate and multivariate statistical analyses used weighted methods to account for the stratified sampling scheme. Only 17.1% of the population had a “desirable” serum 25(OH)D level ≥75 nmol/L, whereas 27.1% had “inadequate” [serum 25(OH)D level 50–74 nmol/L], 40.4% had “insufficient” [serum 25(OH)D level 25–49 nmol/L], and 15.5% had “deficient” [serum 25(OH)D level <25 nmol/L)]. The prevalence of vitamin D deficiency was greater among current smokers, obese subjects, those having reduced HDL-cholesterol level and fair/poor self-perception of health, compared to their counterparts. The prevalence of vitamin D insufficiency was additionally higher among nondrinkers of alcohol, Portuguese and subjects from non-European countries. The final multivariate logistic regression analyses revealed that smoking status and obesity were independent correlates of vitamin D deficiency and insufficiency, respectively. Inadequate vitamin D status is highly prevalent among adults in Luxembourg and is associated with specific lifestyle factors. Along with the effect of vitamin D deficiency and insufficiency on the risk of several diseases, cancer and mortality, our findings have practical implications for public health dietary recommendations, and of particular importance for healthcare practitioners and policy makers.
- 1 November 2010
- Published by Springer Nature in Pediatric Research
- Vol. 68 (1) , 29-30
52 Does Multidisciplinary Group Therapy Improve Outcome in Overweight/Obese Children and Adolescents?
- 1 November 2010
- Published by Springer Nature in Pediatric Research
- Vol. 68 (1) , 29-30
52 Does Multidisciplinary Group Therapy Improve Outcome in Overweight/Obese Children and Adolescents?
- Open Access
- 1 February 2001
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 47 (2) , 331-333
Prolactin Results for Samples Containing Macroprolactin Are Method and Sample Dependent
Prolactin (PRL) exists in human serum in several molecular forms that can be identified by gel-filtration chromatography (GFC). The 23-kDa monomer is the predominant form in the general population, but other circulating species include the 50-kDa form (big PRL) and the 150- to 170-kDa macroprolactin (big big PRL) ( 1)( 2). The prevalence of macroprolactin in the general population is currently unknown, but this macromolecular form of PRL has been characterized as a complex of PRL with an IgG antibody ( 3) that has reduced bioactivity in vivo ( 4) and a variable reactivity with commercial immunoassays for PRL ( 4)( 5)( 6)( 7)( 8). Macroprolactin is cleared from the blood circulation more slowly than monomeric PRL, leading to an apparent hyperprolactinemia, depending on the immunoassay used for the measurement of PRL. Thus, identification of macroprolactin as a cause of high PRL in a patient sample is important because it can help resolve diagnostic confusion and avoid expensive pituitary imaging studies and inappropriate treatment ( 5). As a result of distribution of serum containing macroprolactin in the United Kingdom National External Quality Assessment Scheme, immunoassays for the measurement of PRL have been subdivided into three classes according to their reactivity with macroprolactin: low-, medium-, and high-reading methods ( 6).
- 1 February 2001
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 47 (2) , 331-333
Open AccessProlactin Results for Samples Containing Macroprolactin Are Method and Sample Dependent
Prolactin (PRL) exists in human serum in several molecular forms that can be identified by gel-filtration chromatography (GFC). The 23-kDa monomer is the predominant form in the general population, but other circulating species include the 50-kDa form (big PRL) and the 150- to 170-kDa macroprolactin (big big PRL) ( 1)( 2). The prevalence of macroprolactin in the general population is currently unknown, but this macromolecular form of PRL has been characterized as a complex of PRL with an IgG antibody ( 3) that has reduced bioactivity in vivo ( 4) and a variable reactivity with commercial immunoassays for PRL ( 4)( 5)( 6)( 7)( 8). Macroprolactin is cleared from the blood circulation more slowly than monomeric PRL, leading to an apparent hyperprolactinemia, depending on the immunoassay used for the measurement of PRL. Thus, identification of macroprolactin as a cause of high PRL in a patient sample is important because it can help resolve diagnostic confusion and avoid expensive pituitary imaging studies and inappropriate treatment ( 5). As a result of distribution of serum containing macroprolactin in the United Kingdom National External Quality Assessment Scheme, immunoassays for the measurement of PRL have been subdivided into three classes according to their reactivity with macroprolactin: low-, medium-, and high-reading methods ( 6).
- 1 January 1998
- Vol. 135 (1) , 11-23
[Prostatic cancer in the Grand Duchy of Luxembourg. Role of PSA].
We reviewed the trends in prostate cancer incidence and mortality in Luxembourg between 1983 and 1995 to discuss the importance of total and free PSA in early detection. The study was performed on all the new cases recorded by the National Cancer Registry (Registre Morphologique des Tumeurs). Total and free PSA were measured with the automated Immulite System (DPC, Los Angeles) using a chemoluminescent immunometric assay. The performance of free-to-total serum PSA was analysed by a hospital based study of 113 patients (55 PC, 58 BPH). The age standardized incidence rate increased from 29.3/100,000 in 1983 to 71.5/100,000 in 1995. Mortality rates only changed slightly. The widespread use of PSA testing from 1988 on is probably the main cause of this incidental increase; however no major changes in the age-specific-incidence have been found suggesting the absence of a systematic screening policy by the PSA. The superiority of free-to-total serum PSA ratio in discriminating between cancer and benign condition was confirmed. Early health-conscious man over 50 should be proposed prostate cancer screening by digital rectal examination and PSA. However a systematic screening policy cannot been recommended since a benefit in survival after early treatment has not yet been proven.
- 1 January 1998
- Vol. 135 (1) , 11-23
[Prostatic cancer in the Grand Duchy of Luxembourg. Role of PSA].
We reviewed the trends in prostate cancer incidence and mortality in Luxembourg between 1983 and 1995 to discuss the importance of total and free PSA in early detection. The study was performed on all the new cases recorded by the National Cancer Registry (Registre Morphologique des Tumeurs). Total and free PSA were measured with the automated Immulite System (DPC, Los Angeles) using a chemoluminescent immunometric assay. The performance of free-to-total serum PSA was analysed by a hospital based study of 113 patients (55 PC, 58 BPH). The age standardized incidence rate increased from 29.3/100,000 in 1983 to 71.5/100,000 in 1995. Mortality rates only changed slightly. The widespread use of PSA testing from 1988 on is probably the main cause of this incidental increase; however no major changes in the age-specific-incidence have been found suggesting the absence of a systematic screening policy by the PSA. The superiority of free-to-total serum PSA ratio in discriminating between cancer and benign condition was confirmed. Early health-conscious man over 50 should be proposed prostate cancer screening by digital rectal examination and PSA. However a systematic screening policy cannot been recommended since a benefit in survival after early treatment has not yet been proven.
- 1 July 1997
- Vol. 17, 2861-4
First clinical results with Enzymun-Test for free PSA.
Prostate Specific Antigen (PSA) is widely used for the detection and monitoring of prostate cancer (CAP) but PSA is elevated in many patients with benign prostatic hyperplasia (BPH). The measurement of free PSA may improve the discrimination between CAP and BPH. Free PSA (F-PSA) and total PSA (T-PSA) were measured using kits based on the Enzymun-Test principle. The patient population was composed of 38 untreated CAP patients, 76 BPH patients and 29 prostatitis patients. At cut-off levels of 0.15 for the F-PSA/T-PSA ratio and 10 ng/ml for T-PSA the specificity and sensitivity for detecting CAP were respectively 87% and 84% for F-PSA/T-PSA ratio and 80% and 63% for T-PSA. The F-PSA/T-PSA ratio is more powerful at discriminating between CAP and BPH than T-PSA alone and may contribute to a reduction in unnecessary invasive techniques.
- 1 July 1997
- Vol. 17, 2861-4
First clinical results with Enzymun-Test for free PSA.
Prostate Specific Antigen (PSA) is widely used for the detection and monitoring of prostate cancer (CAP) but PSA is elevated in many patients with benign prostatic hyperplasia (BPH). The measurement of free PSA may improve the discrimination between CAP and BPH. Free PSA (F-PSA) and total PSA (T-PSA) were measured using kits based on the Enzymun-Test principle. The patient population was composed of 38 untreated CAP patients, 76 BPH patients and 29 prostatitis patients. At cut-off levels of 0.15 for the F-PSA/T-PSA ratio and 10 ng/ml for T-PSA the specificity and sensitivity for detecting CAP were respectively 87% and 84% for F-PSA/T-PSA ratio and 80% and 63% for T-PSA. The F-PSA/T-PSA ratio is more powerful at discriminating between CAP and BPH than T-PSA alone and may contribute to a reduction in unnecessary invasive techniques.
- 1 January 1997
- Vol. 134 (2) , 11-5
[The neuropathies of IgM monoclonal gammopathies].
A peripheral polyneuropathy is often associated with an IgM monoclonal gammapathy. The monoclonal protein often binds to carbohydrate epitopes on glycoproteins and/or glycolipids of the human peripheral nerve. The clinical syndrome is related to the antigen-specificity of the IgM protein. Detection of anti-myelin antibodies and further characterization of their immunogenic specificity provide an important aid in the differential diagnosis of late-onset chronic polyneuropathies.
- 1 January 1997
- Vol. 134 (2) , 11-5
[The neuropathies of IgM monoclonal gammopathies].
A peripheral polyneuropathy is often associated with an IgM monoclonal gammapathy. The monoclonal protein often binds to carbohydrate epitopes on glycoproteins and/or glycolipids of the human peripheral nerve. The clinical syndrome is related to the antigen-specificity of the IgM protein. Detection of anti-myelin antibodies and further characterization of their immunogenic specificity provide an important aid in the differential diagnosis of late-onset chronic polyneuropathies.
- 1 January 1996
- Vol. 133 (1) , 13-24
[Autoantibodies in nervous system diseases].